Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF8 antibody (PE)

TNFRSF8 Reactivity: Human FACS Host: Mouse Monoclonal MEM-268 PE
Catalog No. ABIN536665
  • Target See all TNFRSF8 Antibodies
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Reactivity
    • 136
    • 27
    • 18
    • 16
    Human
    Host
    • 90
    • 61
    • 10
    • 4
    • 1
    Mouse
    Clonality
    • 93
    • 71
    • 2
    Monoclonal
    Conjugate
    • 72
    • 13
    • 11
    • 11
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    This TNFRSF8 antibody is conjugated to PE
    Application
    • 103
    • 59
    • 57
    • 45
    • 37
    • 27
    • 26
    • 25
    • 13
    • 8
    • 6
    • 5
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Flow Cytometry (FACS)
    Purpose
    Mouse monoclonal antibody raised against TNFRSF8.
    Specificity
    This antibody recognizes extracellular part of CD30 (Ki-1 antigen), a 105 KDa single chain glycoprotein expressed on Hodgkin's and Reed-Sternberg cells.
    Cross-Reactivity
    Human
    Immunogen
    Expression vector containing CD30 cDNA (booster suspension of THP-1 cell line).
    Clone
    MEM-268
    Isotype
    IgG
    Top Product
    Discover our top product TNFRSF8 Primary Antibody
  • Application Notes
    Flow Cytometry (20 µL in human blood cells 100 µL in whole blood or 106 cells in a suspension)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In PBS (0.2 % BSA, 0.09 % sodium azide)
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C
    Storage Comment
    Store in the dark at 4°C. Do not freeze.
    Avoid prolonged exposure to light.
    Aliquot to avoid repeated freezing and thawing.
  • Kusanovic, Romero, Hassan, Gotsch, Edwin, Chaiworapongsa, Erez, Mittal, Mazaki-Tovi, Soto, Than, Friel, Yoon, Espinoza: "Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies." in: The journal of maternal-fetal & neonatal medicine, Vol. 20, Issue 12, pp. 867-78, (2008) (PubMed).

    Wright, Rumble, Duckett: "CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells." in: The Journal of biological chemistry, Vol. 282, Issue 14, pp. 10252-62, (2007) (PubMed).

    Zeiser, Nguyen, Hou, Beilhack, Zambricki, Buess, Contag, Negrin: "Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease." in: Blood, Vol. 109, Issue 5, pp. 2225-33, (2007) (PubMed).

  • Target
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Alternative Name
    CD30 (TNFRSF8 Products)
    Synonyms
    CD30 antibody, D1S166E antibody, Ki-1 antibody, Cd30 antibody, Ki antibody, TNFRSF8 antibody, TNF receptor superfamily member 8 antibody, tumor necrosis factor receptor superfamily, member 8 antibody, TNFRSF8 antibody, Tnfrsf8 antibody
    Gene ID
    943
You are here:
Support